dc.creator | Castilho, L | |
dc.creator | Rios, M | |
dc.creator | Rodrigues, A | |
dc.creator | Pellegrino, J | |
dc.creator | Saad, S T O | |
dc.creator | Costa, F F | |
dc.date | 2005-Feb | |
dc.date | 2015-11-27T13:02:48Z | |
dc.date | 2015-11-27T13:02:48Z | |
dc.date.accessioned | 2018-03-29T01:02:08Z | |
dc.date.available | 2018-03-29T01:02:08Z | |
dc.identifier | Transfusion Medicine (oxford, England). v. 15, n. 1, p. 49-55, 2005-Feb. | |
dc.identifier | 0958-7578 | |
dc.identifier | 10.1111/j.1365-3148.2005.00548.x | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/15713129 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/196594 | |
dc.identifier | 15713129 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1296827 | |
dc.description | We have set out to determine the frequency of DIIIa and DAR alleles among sickle cell disease (SCD) patients. These D variants permit the unexpected development of antibodies to RhD among individuals who are otherwise classified as RhD+. DNA samples from 130 SCD patients were tested for 455A>C (specific for DIIIa), 602C>G, 667T>G (common for both DIIIa and DAR) and 1025T>C (specific for DAR) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and sequence analysis. The PCR-RFLP showed that 12 (9.2%) of the SCD patients were carrying DIIIa and DAR alleles. Genomic DNA analysis performed by sequence showed that three samples were heterozygous DIIIa (2.3%), seven heterozygous DAR (4.6%) and two (1.5%) samples carried a partial D with four mutations: 455A>C (heterozygous), 602C>G and 667T>G (homozygous) and 1025T>C (heterozygous), indicating compound heterozygosity for one DIIIa allele and one DAR allele. The predicted phenotypes of eight (6.2%) SCD patients were DIIIa, DAR and DIIIa/DAR. Three patients were anti-D immunized (DAR, n = 1; DIIIa/DAR, n = 2). These findings suggest that SCD patients who are candidates for chronic transfusion may benefit from genotyping for DIIIa and DAR to prevent alloimmunization. | |
dc.description | 15 | |
dc.description | 49-55 | |
dc.language | eng | |
dc.relation | Transfusion Medicine (oxford, England) | |
dc.relation | Transfus Med | |
dc.rights | fechado | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Alleles | |
dc.subject | Anemia, Sickle Cell | |
dc.subject | Blood Transfusion | |
dc.subject | Diabetes Mellitus, Type 1 | |
dc.subject | Gene Frequency | |
dc.subject | Humans | |
dc.subject | Immunization | |
dc.subject | Rh-hr Blood-group System | |
dc.subject | Risk Factors | |
dc.title | High Frequency Of Partial Diiia And Dar Alleles Found In Sickle Cell Disease Patients Suggests Increased Risk Of Alloimmunization To Rhd. | |
dc.type | Artículos de revistas | |